Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
about
Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseCustomizing the genome as therapy for the β-hemoglobinopathiesHemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.Biomedical research, a tool to address the health issues that affect African populations.Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyureaA Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approachBCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.A genetic score for the prediction of beta-thalassemia severity.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Losing balance: Hardy-Weinberg disequilibrium as a marker for recurrent loss-of-heterozygosity in cancerCorrelation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.Genetic modifiers of sickle cell diseaseGenetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Applications of high-throughput DNA sequencing to benign hematologyFactors Associated with Growth Retardation in Children Suffering from Sickle Cell Anemia: First Report from Central Africa.Rapid and pervasive changes in genome-wide enhancer usage during mammalian development.Do genome-wide association scans have potential for translation?Emerging science of hydroxyurea therapy for pediatric sickle cell disease.An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.Molecular basis of β thalassemia and potential therapeutic targets.Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.Multiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies.Beta-thalassemia: from genotype to phenotype.ARHGAP18 is a novel gene under positive natural selection that influences HbF levels in β-thalassaemia.Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.A Multi-locus Approach to Characterization of Major Quantitative Trait Loci Influencing Hb F Regulation in Chinese β-thalassemia Carriers.: a genetic model of fetal hemoglobin in sickle cell disease
P2860
Q24202463-08869D01-3A9E-46B6-BE48-A472B6658F0BQ26751061-E21E0492-49CB-44F9-AFBD-45BE6279AC6FQ33361527-8E2031AE-499D-4A66-AD6D-8365F1609D95Q33589357-D16E8124-1047-4A32-B0C1-C5481EAD130FQ34322542-6DB00C62-C83D-4488-A9C9-0FC27D98FC21Q34456358-17078A98-C0E3-4446-8575-18D58952C406Q34586227-D809C146-5A7D-46BF-885C-3182D48EF29BQ34792068-A1F4AD87-4074-4BE5-8055-5D6030A05F33Q35087288-8EC6BF8C-AD8D-448B-8D56-777E9268B913Q35124793-C32F97EF-1CAA-4CF3-BBC4-BCE4083FAD3AQ35236041-9FED9D9E-4E2D-498B-A4C5-6E5B43A7FA5BQ35565624-2F6E0478-39FA-4E93-9846-271928254251Q35565689-D99B9D36-E143-47EF-8F4B-6370CBA05EF3Q35577509-0C6F664C-1BC4-4E1C-BD70-B0B14554C78BQ36035471-E5F00AF1-6FBA-404B-914E-81B799AD4B95Q36094672-EBB6CD96-FCC4-46DB-AEB6-C7D02C201E45Q36232895-CDD82016-62D4-4A3D-9F93-0B314FE2EF85Q36251052-B144DF73-5893-4E74-B9C4-D87435BC4391Q36370980-4D99E2DC-F635-481F-B609-E68FD3B204CBQ37334703-16687769-FC9B-40EA-A802-B931FD59E39DQ37637775-F3616424-62C1-41AD-9167-63BDB3A37731Q37706673-00E1EE19-FCA3-4347-89AE-A90CED4D22FBQ37948858-7D4CA7A8-39A4-43BD-B084-AED6AFD8878BQ38164192-530D8B69-4BF8-4D78-8EB1-5D42042A1FEBQ39081873-B1D9CF10-3D7A-48FE-8A07-1E7F8DDA2471Q39399184-C43C4ECB-E0BB-491B-AA2A-B526C1EEB773Q40278751-70AB23BC-8D70-4EF7-9D4A-2C74A25D187EQ41232448-B4AA2B74-2705-4E83-8BB2-3C67C4B6ED02Q42958714-EE2BD3B8-5456-4329-8401-5EEE071466DDQ47853382-E544D3E4-652B-46A8-BEE9-9377A16A6A3DQ50061134-7B7C8259-E893-4825-8CE6-B453A47FBA2FQ50576368-3BF755EB-C790-43A7-AF31-B9FFB51FD3AFQ58662400-7C2C11F6-5F5D-4784-99F1-1AE3CF814307
P2860
Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genome-wide association study ...... evels in sickle-cell patients.
@ast
Genome-wide association study ...... evels in sickle-cell patients.
@en
Genome-wide association study ...... evels in sickle-cell patients.
@nl
type
label
Genome-wide association study ...... evels in sickle-cell patients.
@ast
Genome-wide association study ...... evels in sickle-cell patients.
@en
Genome-wide association study ...... evels in sickle-cell patients.
@nl
prefLabel
Genome-wide association study ...... evels in sickle-cell patients.
@ast
Genome-wide association study ...... evels in sickle-cell patients.
@en
Genome-wide association study ...... evels in sickle-cell patients.
@nl
P2093
P2860
P921
P356
P1476
Genome-wide association study ...... evels in sickle-cell patients.
@en
P2093
Dan E Arking
Emily Barron-Casella
James F Casella
Jeffrey R Keefer
Michael R DeBaun
Pallav Bhatnagar
Shirley Purvis
P2860
P2888
P304
P356
10.1038/JHG.2011.12
P577
2011-02-17T00:00:00Z